Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.05B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.61B |
| 3 |
Tesla
TSLA
|
+$636M |
| 4 |
TSMC
TSM
|
+$604M |
| 5 |
iShares Bitcoin Trust
IBIT
|
+$330M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.25B |
| 2 |
Apple
AAPL
|
+$1.13B |
| 3 |
Microsoft
MSFT
|
+$988M |
| 4 |
Meta Platforms (Facebook)
META
|
+$572M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$570M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 94.1% |
| 2 | Technology | 1.55% |
| 3 | Consumer Discretionary | 0.95% |
| 4 | Financials | 0.77% |
| 5 | Healthcare | 0.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2626
DexCom
DXCM
$34.3B
| $9.27M | ﹤0.01% |
135,758
-276,679
| -67% | -$22.6M |
|
2627
Immunome
IMNM
$3.13B
| $9.27M | ﹤0.01% |
1,377,053
+1,294,458
| +1,567% | +$12.4M |
|
2628
PUT
Patterson-UTI
PTEN
$4.74B
| $9.25M | ﹤0.01% |
1,124,700
+156,300
| +16% | +$1.31M |
|
2629
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
$17.4B
| $9.24M | ﹤0.01% |
+91,834
| New | +$9.23M |
|
2630
Synaptics
SYNA
$3.72B
| $9.24M | ﹤0.01% |
144,974
+104,271
| +256% | +$7.56M |
|
2631
PUT
MasTec
MTZ
$19.4B
| $9.23M | ﹤0.01% |
79,100
-12,100
| -13% | -$1.63M |
|
2632
Banc of California
BANC
$2.95B
| $9.23M | ﹤0.01% |
650,544
+329,882
| +103% | +$4.99M |
|
2633
Jackson Financial
JXN
$9.09B
| $9.23M | ﹤0.01% |
110,176
+59,287
| +117% | +$5.26M |
|
2634
Medtronic
MDT
$117B
| $9.23M | ﹤0.01% |
102,671
-502,297
| -83% | -$44.9M |
|
2635
Vanguard FTSE Developed Markets ETF
VEA
$238B
| $9.22M | ﹤0.01% |
181,414
-1,471,108
| -89% | -$74.4M |
|
2636
Airbnb
ABNB
$112B
| $9.22M | ﹤0.01% |
77,145
-233,270
| -75% | -$31.3M |
|
2637
Nokia
NOK
$57.2B
| $9.19M | ﹤0.01% |
1,744,135
-1,083,613
| -38% | -$5.3M |
|
2638
CALL
Vanguard Morningstar Small-Cap Growth ETF
VBK
$24B
| $9.19M | ﹤0.01% |
36,500
-5,300
| -13% | -$1.47M |
|
2639
CALL
Chord Energy
CHRD
$7.99B
| $9.19M | ﹤0.01% |
81,500
+46,300
| +132% | +$5.26M |
|
2640
EXL Service
EXLS
$5.82B
| $9.17M | ﹤0.01% |
194,278
+126,392
| +186% | +$6.08M |
|
2641
MetLife
MET
$61.3B
| $9.17M | ﹤0.01% |
114,179
-272,948
| -71% | -$22.7M |
|
2642
CALL
DigitalOcean
DOCN
$13.1B
| $9.15M | ﹤0.01% |
273,900
-99,700
| -27% | -$3.9M |
|
2643
PUT
ProShares Ultra Silver
AGQ
$1.52B
| $9.14M | ﹤0.01% |
198,100
-48,900
| -20% | -$2M |
|
2644
CALL
Broadridge
BR
$20.9B
| $9.14M | ﹤0.01% |
37,700
+16,500
| +78% | +$3.88M |
|
2645
iShares Global Tech ETF
IXN
$9.5B
| $9.13M | ﹤0.01% |
120,541
+57,418
| +91% | +$4.75M |
|
2646
RenaissanceRe
RNR
$13.7B
| $9.13M | ﹤0.01% |
38,031
+10,684
| +39% | +$2.59M |
|
2647
Alcoa
AA
$13.3B
| $9.13M | ﹤0.01% |
299,222
+106,321
| +55% | +$3.72M |
|
2648
Rapid7
RPD
$896M
| $9.12M | ﹤0.01% |
344,083
-206,365
| -37% | -$7.02M |
|
2649
CALL
AeroVironment
AVAV
$7.52B
| $9.12M | ﹤0.01% |
76,500
-68,800
| -47% | -$10.6M |
|
2650
Enovis
ENOV
$1.44B
| $9.11M | ﹤0.01% |
238,488
+126,428
| +113% | +$5.36M |
|
Similar funds
Jeff Yass's Q1 2025 Portfolio in Review
As of Q1 2025, Jeff Yass held 13,842 positions worth $586B, down 12% from $663B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Jeff Yass's Q1 2025 filing shows 1,775 new, 5,712 increased, 4,842 reduced and 1,482 closed positions. Its largest new stake was Brookfield Asset Management: 1,775,684 shares worth $86M. The largest sale was Invesco QQQ Trust, an estimated $1.25B.
By sector, the portfolio is most concentrated in Miscellaneous at 94% of assets, up from 93% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q1 2025 buy was Brookfield Asset Management: 1,775,684 shares worth $86M.
- Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $4.05B increase.
- Jeff Yass's biggest Q1 2025 reduction was Invesco QQQ Trust, cutting an estimated $1.25B.
- Jeff Yass fully exited Inari Medical, Inc. Common Stock in Q1 2025, selling an estimated $24M.
- Jeff Yass's ten largest holdings make up 28% of its $586B portfolio in Q1 2025.
- Jeff Yass opened 1,775 new positions and closed 1,482 in Q1 2025.
- Jeff Yass's portfolio value fell 12% quarter-over-quarter to $586B.
Based on Susquehanna International Group's 13F filing for Q1 2025, filed 14 May 2025.